Literature DB >> 19478446

Crystallization of Mycobacterium smegmatis methionyl-tRNA synthetase in the presence of methionine and adenosine.

Henrik Ingvarsson1, T Alwyn Jones, Torsten Unge.   

Abstract

Methionyl-tRNA synthetase (MetRS) from Mycobacterium smegmatis was recombinantly expressed in Escherichia coli and purified using Ni(2+)-affinity and size-exclusion chromatography. Crystals formed readily in the presence of the ligands methionine and adenosine. These two ligands are components of an intermediate in the two-step catalytic mechanism of MetRS. The crystals were produced using the vapour-diffusion method and a full data set to 2.1 A resolution was collected from a single crystal. The crystal belonged to the monoclinic space group C2, with unit-cell parameters a = 155.9, b = 138.9, c = 123.3 A, beta = 124.8 degrees . The presence of three molecules in the asymmetric unit corresponded to a solvent content of 60% and a Matthews coefficient of 3.1 A(3) Da(-1). Structure determination is in progress.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19478446      PMCID: PMC2688425          DOI: 10.1107/S1744309109016704

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  21 in total

Review 1.  Genomics-based identification of targets in pathogenic bacteria for potential therapeutic and diagnostic use.

Authors:  G Raczniak; M Ibba; D Söll
Journal:  Toxicology       Date:  2001-03-07       Impact factor: 4.221

2.  A homogeneous method to measure aminoacyl-tRNA synthetase aminoacylation activity using scintillation proximity assay technology.

Authors:  R Macarrón; L Mensah; C Cid; C Carranza; N Benson; A J Pope; E Díez
Journal:  Anal Biochem       Date:  2000-09-10       Impact factor: 3.365

Review 3.  Strategies against multidrug-resistant tuberculosis.

Authors:  R Loddenkemper; D Sagebiel; A Brendel
Journal:  Eur Respir J Suppl       Date:  2002-07

Review 4.  Aminoacyl tRNA synthetases as targets for new anti-infectives.

Authors:  P Schimmel; J Tao; J Hill
Journal:  FASEB J       Date:  1998-12       Impact factor: 5.191

5.  Nanomolar inhibitors of Staphylococcus aureus methionyl tRNA synthetase with potent antibacterial activity against gram-positive pathogens.

Authors:  Richard L Jarvest; John M Berge; Valerie Berry; Helen F Boyd; Murray J Brown; John S Elder; Andrew K Forrest; Andrew P Fosberry; Daniel R Gentry; Martin J Hibbs; Deborah D Jaworski; Peter J O'Hanlon; Andrew J Pope; Stephen Rittenhouse; Robert J Sheppard; Courtney Slater-Radosti; Angela Worby
Journal:  J Med Chem       Date:  2002-05-09       Impact factor: 7.446

6.  Partition of tRNA synthetases into two classes based on mutually exclusive sets of sequence motifs.

Authors:  G Eriani; M Delarue; O Poch; J Gangloff; D Moras
Journal:  Nature       Date:  1990-09-13       Impact factor: 49.962

Review 7.  The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice.

Authors:  B D Cookson
Journal:  J Antimicrob Chemother       Date:  1998-01       Impact factor: 5.790

8.  Variable sensitivity to bacterial methionyl-tRNA synthetase inhibitors reveals subpopulations of Streptococcus pneumoniae with two distinct methionyl-tRNA synthetase genes.

Authors:  Daniel R Gentry; Karen A Ingraham; Michael J Stanhope; Stephen Rittenhouse; Richard L Jarvest; Peter J O'Hanlon; James R Brown; David J Holmes
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

9.  Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use.

Authors:  R Sutherland; R J Boon; K E Griffin; P J Masters; B Slocombe; A R White
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  2 in total

Review 1.  Adenylating enzymes in Mycobacterium tuberculosis as drug targets.

Authors:  Benjamin P Duckworth; Kathryn M Nelson; Courtney C Aldrich
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

2.  Structural characterization of free-state and product-state Mycobacterium tuberculosis methionyl-tRNA synthetase reveals an induced-fit ligand-recognition mechanism.

Authors:  Wei Wang; Bo Qin; Justyna Aleksandra Wojdyla; Meitian Wang; Xiaopan Gao; Sheng Cui
Journal:  IUCrJ       Date:  2018-06-22       Impact factor: 4.769

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.